Search Results - "Tong, Luqing"
-
1
Notch1 signaling pathway promotes invasion, self-renewal and growth of glioma initiating cells via modulating chemokine system CXCL12/CXCR4
Published in Journal of experimental & clinical cancer research (05-08-2019)“…Glioma initiating cells (GICs), also known as glioma stem cells (GSCs), play an important role in the progression and recurrence of glioblastoma multiforme…”
Get full text
Journal Article -
2
Proteomics shows that brain metastases of lung adenocarcinoma overexpress ribosomal proteins in response to gamma knife radiosurgery
Published in Scientific reports (08-07-2024)“…Gamma knife radiosurgery (GKRS) is recommended as the first-line treatment for brain metastases of lung adenocarcinoma (LUAD) in many guidelines, but its…”
Get full text
Journal Article -
3
Molecular and clinical characterization of Galectin‐9 in glioma through 1,027 samples
Published in Journal of cellular physiology (01-05-2020)“…In recent years, research on glioma immunotherapy have grown rapidly. However, the autoimmune‐like side effects that are caused by blocking immunological…”
Get full text
Journal Article -
4
Immunological and clinicopathological characteristics of C1RL in 2120 glioma patients
Published in BMC cancer (29-09-2020)“…Glioma is a deadly and immunosuppressive brain tumour. Complement C1r subcomponent like (C1RL), a prognostic biomarker in several kinds of tumours, has…”
Get full text
Journal Article -
5
CLEC5A expressed on myeloid cells as a M2 biomarker relates to immunosuppression and decreased survival in patients with glioma
Published in Cancer gene therapy (01-09-2020)“…Glioma is the most common tumor in the central nervous system that portends a poor prognosis. Key genes negatively related to survival may provide targets for…”
Get full text
Journal Article -
6
Autophagy suppresses self-renewal ability and tumorigenicity of glioma-initiating cells and promotes Notch1 degradation
Published in Cell death & disease (18-10-2018)“…Autophagy is a vital process that involves degradation of long-lived proteins and dysfunctional organelles and contributes to cellular metabolism…”
Get full text
Journal Article -
7
Combination checkpoint therapy with anti-PD-1 and anti-BTLA results in a synergistic therapeutic effect against murine glioblastoma
Published in Oncoimmunology (01-01-2021)“…Clinical trials involving anti-programmed cell death protein-1 (anti-PD-1) failed to demonstrate improved overall survival in glioblastoma (GBM) patients. This…”
Get full text
Journal Article -
8
Sustained localized delivery of immunotherapy to lymph nodes reverses immunosuppression and increases long-term survival in murine glioblastoma
Published in Oncoimmunology (01-01-2021)“…Despite the advent of immunotherapy as a promising therapeutic, glioblastoma (GBM) remains resistant to using checkpoint blockade due to its highly…”
Get full text
Journal Article -
9
Jagged1 is Clinically Prognostic and Promotes Invasion of Glioma-Initiating Cells by Activating NF-κB(p65) Signaling
Published in Cellular physiology and biochemistry (01-01-2019)“…Background/Aims: Jagged1 is the ligands of the Notch signaling and has been shown to promote glioma-initiating cells (GICs) in glioblastoma. The role of…”
Get full text
Journal Article -
10
A contemporary molecular view of diffuse gliomas with implications for diagnosis
Published in Glioma (Mumbai, India) (01-04-2020)“…Diffuse gliomas are a family of neoplastic diseases characterized by widespread infiltration of central nervous system structures by tumor cells displaying…”
Get full text
Journal Article -
11
IKBKE, a prognostic factor preferentially expressed in mesenchymal glioblastoma, modulates tumoral immunosuppression through the STAT3/PD‐L1 pathway
Published in Clinical and translational medicine (01-07-2020)“…Inhibitor of nuclear factor kappa‐B kinase subunit epsilon (IKBKE) plays critical roles in the proliferation, invasion, and epithelial‐mesenchymal transition…”
Get full text
Journal Article -
12
ACT001 reduces the expression of PD-L1 by inhibiting the phosphorylation of STAT3 in glioblastoma
Published in Theranostics (01-01-2020)“…ACT001, which is derived from an ancient anti-inflammatory drug, has been shown to cross the blood-brain barrier in preclinical studies and has demonstrated…”
Get full text
Journal Article -
13
1241 Sustained Localized Delivery of Anti-PD-1 to Tumor Draining Lymph Nodes Increases Survival and Reverses Immunosuppression in Murine Glioblastoma Models
Published in Neurosurgery (01-04-2024)“…INTRODUCTION: Despite the advent of immunotherapy as a promising therapeutic, glioblastoma (GBM) remains resistant to using checkpoint blockade against…”
Get full text
Journal Article -
14
TMIC-14. CLEC5A REGULATES TAM POLARIZATION, TME IMMUNOSUPPRESSION AND DISEASE PROGRESSION IN GLIOBLASTOMA
Published in Neuro-oncology (Charlottesville, Va.) (10-11-2023)“…Abstract Glioblastoma, IDH-wildtype (WHO grade 4) is the most common primary malignant brain tumor of adults and is characterized by an immunosuppressive tumor…”
Get full text
Journal Article -
15
Prognostic value of carcinoembryonic antigen on outcome in patients with coronavirus disease 2019
Published in The Journal of infection (01-08-2020)Get full text
Journal Article -
16
TMIC-21. THE ROLE OF CLEC5A ON M2-LIKE TUMOR-ASSOCIATED MACROPHAGES POLARIZATION AND DISEASE PROGRESSION IN GLIOBLASTOMA
Published in Neuro-oncology (Charlottesville, Va.) (14-11-2022)“…Abstract Glioblastoma, IDH-wildtype (GBM, WHO grade 4) is the most common primary intracranial malignant tumor of adults and is characterized by an…”
Get full text
Journal Article -
17
NKCC1 promotes EMT‐like process in GBM via RhoA and Rac1 signaling pathways
Published in Journal of cellular physiology (01-02-2019)“…Glioblastoma is the most common and lethal primary intracranial tumor. As the key regulator of tumor cell volume, sodium‐potassium‐chloride cotransporter 1…”
Get full text
Journal Article -
18
TMEM158 promotes the proliferation and migration of glioma cells via STAT3 signaling in glioblastomas
Published in Cancer gene therapy (01-08-2022)“…Glioblastoma is the most common primary intracranial malignant tumor in adults and has high morbidity and high mortality. TMEM158 has been reported to promote…”
Get full text
Journal Article -
19
Synergy between glutamate modulation and anti-programmed cell death protein 1 immunotherapy for glioblastoma
Published in Journal of neurosurgery (01-02-2022)“…Immune checkpoint inhibitors such as anti-programmed cell death protein 1 (anti-PD-1) have shown promise for the treatment of cancers such as melanoma, but…”
Get full text
Journal Article -
20
Glutamate Modulation Synergizes With Anti-PD-1 Immunotherapy in Glioblastoma
Published in Neurosurgery (01-12-2020)“…INTRODUCTION Immune checkpoint inhibitors such as anti-PD-1 have shown promise in other cancers such as melanoma, but results in GBM have been disappointing…”
Get full text
Journal Article